Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
15.94
+0.06 (0.38%)
At close: Oct 4, 2024, 4:00 PM
15.15
-0.79 (-4.96%)
After-hours: Oct 4, 2024, 5:32 PM EDT
Centessa Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -157.35 | -151.09 | -216.21 | -381.9 | -10.66 | -5.06 |
| Depreciation & Amortization | 0.36 | 0.31 | 0.13 | 0.03 | - | 0.01 |
| Other Amortization | 0.6 | 0.5 | - | - | - | - |
| Asset Writedown & Restructuring Costs | - | - | - | 220.45 | - | - |
| Stock-Based Compensation | 31.75 | 29.39 | 24.97 | 14.85 | 0.34 | 0.24 |
| Other Operating Activities | 1.16 | -20.63 | -6.78 | 16.43 | 0.24 | 0.06 |
| Change in Accounts Payable | -5.77 | -2.72 | 6.35 | 3.8 | -0.05 | 0.86 |
| Change in Other Net Operating Assets | -17.07 | -16.11 | -9.01 | -9.83 | -0.5 | -1.92 |
| Operating Cash Flow | -146.31 | -160.34 | -200.55 | -136.16 | -10.63 | -5.83 |
| Capital Expenditures | -0.07 | -0.17 | -1.14 | -0.19 | - | - |
| Cash Acquisitions | - | - | - | 63.44 | - | - |
| Investment in Securities | -8.2 | -126.84 | - | - | - | - |
| Other Investing Activities | - | - | 0.21 | - | - | - |
| Investing Cash Flow | -8.27 | -127 | -0.93 | 63.26 | - | - |
| Long-Term Debt Issued | - | - | - | 73.93 | 1.36 | 3.83 |
| Net Debt Issued (Repaid) | - | - | - | 73.93 | 1.36 | 3.83 |
| Issuance of Common Stock | 139.67 | 21.12 | 0.72 | 344.92 | - | - |
| Other Financing Activities | -2.76 | - | -0.26 | -0.3 | 0 | 0.01 |
| Financing Cash Flow | 136.91 | 21.12 | 0.46 | 660.15 | 1.36 | 9.01 |
| Foreign Exchange Rate Adjustments | -0.19 | 0.62 | -0.42 | 1.9 | -0.08 | 0.52 |
| Net Cash Flow | -17.85 | -265.61 | -201.44 | 589.15 | -9.34 | 3.7 |
| Free Cash Flow | -146.38 | -160.51 | -201.68 | -136.34 | -10.63 | -5.83 |
| Free Cash Flow Margin | -2135.98% | -2342.20% | - | - | - | - |
| Free Cash Flow Per Share | -1.45 | -1.67 | -2.16 | -1.81 | -0.71 | - |
| Cash Interest Paid | 10.16 | 9.91 | 7.28 | 1.48 | - | - |
| Cash Income Tax Paid | 0.24 | 2.94 | 1.3 | - | - | - |
| Levered Free Cash Flow | -91.92 | -97.11 | -108.73 | -82.08 | - | - |
| Unlevered Free Cash Flow | -85.56 | -90.92 | -104.18 | -80.49 | - | - |
| Change in Net Working Capital | 21.05 | 13.9 | -3.29 | 8.11 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.